GSK
GlaxoSmithKline PLC ADRNYSE
Healthcare • Drug Manufacturers - General
Updated 1 day ago
Coverage limited
Factor tilt: Quality-tilted Large Cap
$46.27-1.39%
Close Oct 13, 2026
- Market cap
- $92.67B
- 1 month
- -7.6%
- 3 months
- -10.1%
- 1 year
- +6.3%
- 52-week range
- $43.24$61.18
- Dividend, last 12 mo
- $1.8233 · 3.94% yield
- Last ex-date
- Aug 14, 2026 · $0.4515
- Dividend growth
- 2+ years in a row
- Short interest
- 14.8M sharessettled Sep 30, 2026 · +1.0% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if GSK is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
137 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
1,046 filers reported a long position in GSK for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $3.4B | 65M | -4% |
| DODGE & COX | $2.5B | 48.2M | -17.8% |
| Fisher Asset Management, LLC | $1.9B | 35.7M | +3.5% |
| PRIMECAP MANAGEMENT CO/CA/ | $1.3B | 25.2M | -0.1% |
| WELLINGTON MANAGEMENT GROUP LLP | $597.4M | 11.4M | -2.7% |
| JTC Employer Solutions Trustee Ltd | $450.3M | 8.6M | -5% |
| MORGAN STANLEY | $401.4M | 7.7M | -30.6% |
| ROYAL BANK OF CANADA | $397.8M | 7.6M | +1.1% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $362.9M | 6.9M | -5.5% |
| ACADIAN ASSET MANAGEMENT LLC | $349.1M | 6.7M | -43.5% |
Get the Full Analysis for GSK
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.